MAPT and Mental deterioration: Moreover, increasing evidence indicates that soluble Aβ oligomers and the intermediate products of APP cleavage by β-secretase (CTFs) could also trigger tau alterations and contribute to neurotoxicity and neurodegeneration [1,69], leading to cognitive decline.